Bspkl
John Sharpe is an experienced professional currently serving as the EVP of Flow Cytometry at STgenetics since October 2021. In addition, John holds the position of COO at Cytonome, where involvement has spanned since February 2009. John has contributed to various roles across multiple companies, including Director at Bspkl, GNS Science, Chronoptics, STgenetics New Zealand, and Photara Technologies Limited. Previously, John held positions such as CTO and CEO, and worked as a Senior Scientist at Plant and Food Research and as Business Manager at DairyNZ. John has a PhD in Physics from The University of Waikato, earned between 1988 and 1997.
This person is not in the org chart
This person is not in any teams
Bspkl
We believe innovative manufacturing approaches are needed to support the transition to a sustainable and low-carbon world. Our Catalyst Coated Membrane products have been developed to support this goal through the creation of a high performing CCM, with the lowest known catalyst loading for CCM. Bspkl is a New Zealand-based manufacturer of high-performance catalyst coated membranes. Our capabilities leverage new and innovative manufacturing approaches to deliver a range of sustainable technologies, currently for PEM electrolysis, with plans to expand into AEM, Fuel Cells and other energy related technologies in the near future. Being NZ’s first Hydrogen deep technology start up, we are passionate about combining the best of NZ’s research and technology capabilities to unlock new technologies to combat the developing climate crisis. Our ambition is to make a genuine difference in the world, opening pathways for the scientists, startups and our employees that who come behind us.